Neuronetics And 3 Other Stocks Under $3 Insiders Are Buying
The Dow Jones index closed higher by around 80 points on Thursday. When insiders purchase or sell shares,…
Nasdaq Moves Lower; Great Lakes Dredge & Dock Shares Surge Following Upbeat Earnings
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling around 0.2% on Tuesday.…
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
Shares of Beyond, Inc. (NYSE:BYON) fell sharply during Tuesday’s session following weaker-than-expected quarterly results. Beyond posted adjusted loss of…
12 Health Care Stocks Moving In Tuesday’s Intraday Session
Gainers Nuwellis (NASDAQ:NUWE) shares rose 57.7% to $0.27 during Tuesday’s regular session. The company’s market cap stands at…
Crude Oil Edges Lower; UBS Shares Jump After Q1 Earnings
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 75 points on Tuesday.…
Neuronetics, Inc. Announces New Publication In Brain Stimulation Confirms Full TMS Treatment Course Is Vital
Neuronetics, Inc. (NASDAQ:STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders,
Top 5 Health Care Stocks That May Plunge In March
As of March 28, 2024, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Neuronetics Reports FY23 Preliminary Unaudited Total Revenue Is Expected To Be Over $71M As Compared To Previously Stated Guidance Of $70M-$72M
Full Year 2023Preliminary unaudited total revenue is expected to be over $71 million as compared to previously stated guidance of $70.0 to $72.0 million."2023 was an exciting year at Neuronetics. The momentum we built
Neuronetics Receives FDA 510(k) Clearance For NeuroSite Coil Placement Accessory That Simplifies Measurement And Coil Positioning During Neurostar Transcranial Magnetic Stimulation Treatments
Neuronetics, Inc. (NASDAQ:STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced the
NeuroStar Elevates Depression Treatment With Cutting-Edge Technology Advancements
Neuronetics, Inc. (NASDAQ:STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced